{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:06:42Z","timestamp":1790201202401,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cysticfibrosisjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jcf.2016.10.001","type":"journal-article","created":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T21:45:46Z","timestamp":1477518346000},"page":"13-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["The fate of inhaled antibiotics after deposition in cystic fibrosis: How to get drug to the bug?"],"prefix":"10.1016","volume":"16","author":[{"given":"Aukje C.","family":"Bos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly M.","family":"Pass\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan W.","family":"Mouton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hettie M.","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm A.W.M.","family":"Tiddens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2016.10.001_bb0005","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/S1569-1993(16)30355-1","article-title":"The fate of inhaled antibiotics after deposition in patients with cystic fibrosis: how to get drug to the bug?","volume":"15","author":"Bos","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2016.10.001_bb0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1172\/JCI0213870","article-title":"Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients","volume":"109","author":"Worlitzsch","year":"2002","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.jcf.2016.10.001_bb0015","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/JCM.43.10.5085-5090.2005","article-title":"Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions","volume":"43","author":"Hill","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.jcf.2016.10.001_bb0020","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/AAC.32.4.518","article-title":"Inhibition of tobramycin diffusion by binding to alginate","volume":"32","author":"Nichols","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"issue":"7454","key":"10.1016\/j.jcf.2016.10.001_bb0025","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.jcf.2016.10.001_bb0030","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"issue":"4","key":"10.1016\/j.jcf.2016.10.001_bb0035","first-page":"386","article-title":"Influence of secretor and non-secretor phenotypes on the solubilization of pulmonary mucus by three common medicines in cystic fibrosis patients assessed using photoacoustic analysis","volume":"4","author":"Barboza","year":"2008","journal-title":"Arch Med Sci"},{"issue":"012018","key":"10.1016\/j.jcf.2016.10.001_bb0040","first-page":"1","article-title":"Photoacoustic analysis of the solubilization kinetics of pulmonary secretions from cystic fibrosis patients \u2013 secretor and non-secretor phenotypes","volume":"214","author":"Barja","year":"2010","journal-title":"J Phys Conf Ser"},{"issue":"6","key":"10.1016\/j.jcf.2016.10.001_bb0045","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1021\/js950381s","article-title":"Drug diffusion through cystic fibrotic mucus: steady-state permeation, rheologic properties, and glycoprotein morphology","volume":"85","author":"Bhat","year":"1996","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.jcf.2016.10.001_bb0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jac\/dkp165","article-title":"Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa","volume":"64","author":"Alipour","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jcf.2016.10.001_bb0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jac\/27.3.285","article-title":"The diffusion of beta-lactam antibiotics through mixed gels of cystic fibrosis-derived mucin and Pseudomonas aeruginosa alginate","volume":"27","author":"Bolister","year":"1991","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jcf.2016.10.001_bb0060","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijpharm.2012.05.077","article-title":"Gentamicin and leucine inhalable powder: what about antipseudomonal activity and permeation through cystic fibrosis mucus?","volume":"440","author":"Russo","year":"2013","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.jcf.2016.10.001_bb0065","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/bit.23046","article-title":"Mannitol-guided delivery of Ciprofloxacin in artificial cystic fibrosis mucus model","volume":"108","author":"Yang","year":"2011","journal-title":"Biotechnol Bioeng"},{"issue":"Suppl. 58","key":"10.1016\/j.jcf.2016.10.001_bb0070","first-page":"3443","article-title":"Late-breaking abstract: sweetening antibiotic treatment for eradication of bacteria biofilm","volume":"44","author":"Ong","year":"2014","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.jcf.2016.10.001_bb0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11095-009-9991-2","article-title":"Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis","volume":"27","author":"Yang","year":"2010","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.jcf.2016.10.001_bb0080","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/ja803925n","article-title":"Cationic amphiphiles increase activity of aminoglycoside antibiotic tobramycin in the presence of airway polyelectrolytes","volume":"131","author":"Purdy Drew","year":"2009","journal-title":"J Am Chem Soc"},{"issue":"4","key":"10.1016\/j.jcf.2016.10.001_bb0085","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jac\/22.4.483","article-title":"The binding of anti-pseudomonal antibiotics to macromolecules from cystic fibrosis sputum","volume":"22","author":"Ramphal","year":"1988","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jcf.2016.10.001_bb0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1128\/AAC.39.1.34","article-title":"Macromolecular mechanisms of sputum inhibition of tobramycin activity","volume":"39","author":"Hunt","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jcf.2016.10.001_bb0095","first-page":"761","article-title":"Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum","volume":"132","author":"Mendelman","year":"1985","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"10.1016\/j.jcf.2016.10.001_bb0100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jac\/29.5.499","article-title":"The binding of amikacin to macromolecules from the sputum of patients suffering from respiratory diseases","volume":"29","author":"Bataillon","year":"1992","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jcf.2016.10.001_bb0105","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/infdis\/148.6.1069","article-title":"Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum","volume":"148","author":"Levy","year":"1983","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jcf.2016.10.001_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1164\/arrd.1983.127.1.39","article-title":"Endobronchial pH. Relevance of aminoglycoside activity in gram-negative bacillary pneumonia","volume":"127","author":"Bodem","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jcf.2016.10.001_bb0115","first-page":"176","article-title":"Effects of sputum from patients with cystic fibrosis on the activity in vitro of 5 antimicrobial drugs on Pseudomonas aeruginosa","volume":"117","author":"Davis","year":"1978","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"10.1016\/j.jcf.2016.10.001_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005724","article-title":"Activity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosis","volume":"4","author":"Alipour","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jcf.2016.10.001_bb0125","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/jac\/dkn059","article-title":"Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections","volume":"61","author":"Meers","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.jcf.2016.10.001_bb0130","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/jac\/dkm289","article-title":"Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia","volume":"60","author":"Halwani","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jcf.2016.10.001_bb0135","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jac\/dkh518","article-title":"Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients","volume":"55","author":"Mugabe","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jcf.2016.10.001_bb0140","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S1569-1993(10)60163-4","article-title":"Effect of saline concentration on the minimum inhibitory concentration of colistimethate sodium and tobramycin","volume":"9","author":"Potter","year":"2010","journal-title":"J Cyst Fibros"},{"issue":"12","key":"10.1016\/j.jcf.2016.10.001_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084220","article-title":"Mannitol enhances antibiotic sensitivity of persister bacteria in Pseudomonas aeruginosa biofilms","volume":"8","author":"Barraud","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jcf.2016.10.001_bb0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.diagmicrobio.2009.09.009","article-title":"Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients","volume":"66","author":"King","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.jcf.2016.10.001_bb0155","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/AAC.48.7.2659-2664.2004","article-title":"Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms","volume":"48","author":"Borriello","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jcf.2016.10.001_bb0160","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.diagmicrobio.2015.01.006","article-title":"In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under \u201ccystic fibrosis-like\u201d physicochemical conditions","volume":"82","author":"Pompilio","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.jcf.2016.10.001_bb0165","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/infdis\/134.5.500","article-title":"Role of ionic strength in salt antagonism of aminoglycoside action on Escherichia coli and Pseudomonas aeruginosa","volume":"134","author":"Beggs","year":"1976","journal-title":"J Infect Dis"},{"issue":"8245","key":"10.1016\/j.jcf.2016.10.001_bb0170","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0140-6736(81)90885-0","article-title":"The penetration of antibiotics through sodium alginate and through the exopolysaccharide of a mucoid strain of Pseudomonas aeruginosa","volume":"2","author":"Slack","year":"1981","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jcf.2016.10.001_bb0175","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/jac\/22.5.667","article-title":"Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa","volume":"22","author":"Gordon","year":"1988","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jcf.2016.10.001_bb0180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1128\/AAC.25.6.673","article-title":"Inability of purified Pseudomonas aeruginosa exopolysaccharide to bind selected antibiotics","volume":"25","author":"Tannenbaum","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jcf.2016.10.001_bb0185","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1128\/AAC.42.4.974","article-title":"Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa","volume":"42","author":"Hatch","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jcf.2016.10.001_bb0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijantimicag.2012.04.015","article-title":"Nutrient dispersion enhances conventional antibiotic activity against Pseudomonas aeruginosa biofilms","volume":"40","author":"Sommerfeld Ross","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jcf.2016.10.001_bb0195","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/jac\/dku357","article-title":"Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells","volume":"70","author":"Moreau-Marquis","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jcf.2016.10.001_bb0200","first-page":"318","article-title":"ALX-009 potentiates the effect of tobramycin at killing Pseudomonas aeruginosa biofilms on human airway cells","volume":"47","author":"Moreau-Marquis","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2016.10.001_bb0205","first-page":"318","article-title":"Treatment with ALX-009 in combination with aztreonam potentiates the killing of Pseudomonas aeruginosa biofilms on human CF airway cells","volume":"47","author":"Moreau-Marquis","year":"2012","journal-title":"Pediatr Pulmonol"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199316306130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199316306130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T01:18:24Z","timestamp":1546305504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199316306130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1569199316306130"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2016.10.001","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The fate of inhaled antibiotics after deposition in cystic fibrosis: How to get drug to the bug?","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2016.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}